BioNTech settles with NIH, UPenn in Covid vaccine disputes and will pay royalties
BioNTech has entered into settlement agreements with the NIH and the University of Pennsylvania, marking a key turning point in the long-running disputes and the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.